192 Shareholder information Five year record A record of financial performance is provided, analysed in accordance with current reporting practice.
The information included in the Five year record is prepared in accordance with IFRS as adopted by the European Union and also with IFRS as issued by the International Accounting Standards Board.
2009 2008 2007 2006 2005 Consumer Healthcare turnover m m m m m OTC medicines 2,319 1,935 1,788 1,561 1,515 Oral healthcare 1,484 1,240 1,049 993 943 Nutritional healthcare 851 796 716 658 619 4,654 3,971 3,553 3,212 3,077 GSK Annual Report 2009 Shareholder information P183204 Business review P06P53 Governance and remuneration P54P90 Financial statements P91P182 Shareholder information P183P204 193 Shareholder information 2009 2008 2007 2006 2005 Financial results total m m m m m Turnover 28,368 24,352 22,716 23,225 21,660 Operating profit 8,425 7,141 7,593 7,808 6,874 Profit before taxation 7,891 6,659 7,452 7,799 6,732 Profit after taxation 5,669 4,712 5,310 5,498 4,816 pence pence pence pence pence Basic earnings per share 109.1 88.6 94.4 95.5 82.6 Diluted earnings per share 108.2 88.1 93.7 94.5 82.0 2009 2008 2007 Financial results before major restructuring m m m Turnover 28,368 24,352 22,716 Operating profit 9,257 8,259 7,931 Profit before taxation 8,726 7,782 7,790 Profit after taxation 6,283 5,551 5,571 pence pence Adjusted earnings per share 121.2 104.7 Adjusted diluted earnings per share 120.3 104.1 2009 2008 2007 2006 2005 millions millions millions millions millions Weighted average number of shares in issue: Basic 5,069 5,195 5,524 5,643 5,674 Diluted 5,108 5,226 5,567 5,700 5,720 % % % % % Return on capital employed 82.8 73.1 76.2 90.6 99.7 Return on capital employed is calculated as total profit before taxation as a percentage of average net assets over the year.
